SUSAN LEPHART: Open Payments
NPI 1194976647 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 16 payments from 10 companies in 2025. Trend: 2023 $1,183 · 2024 $2,250 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $155 |
| Averitas Pharma Inc. | 2 | $62 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Dexcom, Inc. | 1 | $30 |
| IBSA Pharma Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: MINIMED 780G, QUTENZA, ISTURISA, MOUNJARO, Dexcom G6 Transmitter, Tirosint, UBRELVY, GVOKE HYPOPEN.
Industry payments across FL — which companies pay providers there.
